When we looked at the growth of the individual index tumours (defined as the largest tumour at the time of sacrifice) in the different cohorts after 40 days, we saw that all AZD8931-treated MMTV-NIC PTEN+/+ tumours initially responded to treatment and two out of five tumours fully resolved. The gene discussed is PTEN; the disease is neoplasm.